Bibliographical noteFunding Information:
BVN receives research support from Millennium Pharmaceuticals, Inc., Cambridge, MA, and Onyx Pharmaceuticals, Inc., South San Francisco, CA, USA. The remaining authors declare no conflict of interest.
H. A.F. Stessman, A. Lulla, T. Xia, A. Mitra, T. Harding, A. Mansoor, C. L. Myers, B. G. Van Ness, N. G. Dolloff
Research output: Contribution to journal › Letter › peer-review